Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003768464 | SCV004643562 | uncertain significance | not provided | 2023-07-28 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 389 of the CFI protein (p.Arg389Cys). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CFI protein function. ClinVar contains an entry for this variant (Variation ID: 635432). This variant has not been reported in the literature in individuals affected with CFI-related conditions. |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000786883 | SCV000925782 | likely pathogenic | Atypical hemolytic-uremic syndrome with I factor anomaly | 2018-09-28 | no assertion criteria provided | clinical testing |